Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Madison R Dietl

1PUBLICATIONS

11CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 11, 2025

TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy against Ovarian Cancer.

Mitchell T McGinty, Audrey M Putelo, Sree H Kolli

Pageof 1

Frequent Collaborators

1 joint publications

Mitchell T McGinty

1 joint publications

Audrey M Putelo

1 joint publications

Sree H Kolli

1 joint publications

Tzu-Yu Feng

1 joint publications

Cara N Hatzinger

1 joint publications

Simona Bajgai

1 joint publications

Mika K Poblete

1 joint publications

Francesca N Azar

1 joint publications

Anwaruddin Mohammad

1 joint publications

Pankaj Kumar

Frequent Collaborators

1 joint publications

Mitchell T McGinty

1 joint publications

Audrey M Putelo

1 joint publications

Sree H Kolli

1 joint publications

Tzu-Yu Feng

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos